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Several recent findings challenge our view of the heart as a postmitotic organ and suggest that the adult heart
has some capacity to regenerate. Bersell et al. in a recent issue of Cell report that neuregulin1-mediated acti-
vation of ErbB2/4 receptors induces proliferation of adult mononuclear cardiomyocytes.The once widely held views that mamma-
lian cardiomyocytes stop proliferating
early after birth and that the heart itself
is a postmitotic organ are now fading
(Anversa and Nadal-Ginard, 2002). Sev-
eral reports using genetic fate-mapping
techniques in mice (Hsieh et al., 2007) or
assessing the concentration of carbon-14-
labeled nucleic acids in human cardiomyo-
cytes (Bergmann et al., 2009) suggest a
continuous replacement of myocardial
cells during the lifetime of mammals. In
principal, replacement of functional, termi-
nally differentiated cardiomyocytes might
occur via two different routes: (1) pro-
liferation and differentiation of cardiac or
other progenitor cells and (2) proliferation
of differentiated cardiomyocytes. These
routes need not be mutually exclusive but
may be complementing alternatives that
contribute to the renewal of the myocar-
dium to different degrees and under dif-
ferent conditions. So far, researchers have
concentrated on the detection and func-
tional analysis of cardiac stem cells,
a concept that has already led to clinical
applications (reviewed by Dimmeler et al.,
2008). In contrast, stimulating division and
proliferation of mature adult cardiomyo-
cytes has been less popular, in particular
since it is rather difficult to activate cell divi-
sion in mature cardiomyocytes, a fact that
might also be responsible for the rare
formation of myocardial tumors and the
lack of success in obtaining spontaneously
immortalized cardiomyocyte cell lines.
Yet, several groups have reported reac-
tivation of the cell cycle by either
removing cell cycle inhibitors (e.g., p27)
or by overexpressing cell cycle activators
such as cyclinD1, E2F2, expression of
SV40 large T, dominant interfering p53
and others. The rate of cell cycle activa-tion, however, was always relatively low
when applying stringent criteria for the
identification of cycling cardiomyocytes.
In addition, in most of these studies cardi-
omyocytes showed changes in gene
expression consistent with the possibility
that increased proliferation was due to
cell cycle reentry of remnants of embry-
onic cardiomyocytes or precursor cells
(reviewed by Rubart and Field, 2006). It
therefore came as a surprise that the
activation of specific signaling pathways
by FGF-1 (together with the inhibition
of p38) or periostin (a heterofunctional
secreted extracellular matrix protein)
could induce up to 1.3% of rat ventricular
cardiomyocytes to initiate DNA synthesis
and that roughly 50%of these cardiomyo-
cytes then go into cytokinesis. In an article
in Cell, Bersell et al. (2009) now uncover
an additional pathway, in which Neuregu-
lin1 stimulates cardiomyocyte prolifera-
tion in the adult heart via activation of
the tyrosine kinase receptors erbB2/4.
Neuregulin1 and its receptors are well
known to be essential for heart develop-
ment and were thought to control embry-
onic cardiomyocyte proliferation. In adult
cardiomyocytes, Bersell et al. (2009)
now demonstrate that Neuregulin1 drives
up to 20% of mononuclear (but not binu-
clear) cardiomyocytes into DNA syn-
thesis. Since less than 10% of the cardio-
myoyctes in the adult mouse heart are
mononucleated, only a small subpopula-
tion responds to Neuregulin1. Further-
more, the proportion of cells that initiate
cytokinesis in vivo is even smaller, corre-
sponding to about 0.3% of mononuclear
cardiomyocytes (Figure 1A). Still, the fact
that these cardiomyocytes are able to
proliferate at all is surprising. Using a
broad array of different techniquesDevelopmental Cellincluding cell tracing and differential cell
labeling, Bersell et al. (2009) demonstrate
that activated cardiomyocytes prolifer-
ated clonally in vivo without an apparent
contribution of cardiac progenitor cells.
How do differentiated cardiomyocytes
divide? Neuregulin1-treated mononucle-
ated cardiomyocytes appear to disas-
semble the contractile apparatus by
a partial resorption of the sarcomeric Z
disks (Figure 1A), which at least superfi-
cially resembles the sequential myofi-
brillar breakdown observed in dividing
embryonic cardiomyocytes. Furthermore,
neuregulin1, applied 2 weeks after induc-
tion of an acute myocardial infarction,
improved cardiac function, implying a
therapeutic potential. If considered for
the treatment for chronic heart failure,
however, it remains to be shown that the
subset of cardiomyocytes capable of
dividing in response to neuregulin1 is still
present and responsive in chronic disease
states, especially given that ErbB recep-
tors are downregulated during heart
failure or pressure overload. Neverthe-
less, systemic application of recombinant
neuregulin1 improved cardiac function in
ischemic and nonischemic models of
heart failure (Liu et al., 2006) although it
remains to be determined whether these
therapeutic benefits are due to enhanced
cardiomyocyte proliferation or mediated
by the various other known effects of neu-
regulin1 (e.g., effects on survival, cell
integrity, and enhanced angiogenesis).
In embryonic heart development, Neu-
regulin1 is expressed in the endocardium
under control of the Notch and Ephrin
signaling pathways, where it signals to
its cognate receptors erbB2 and erbB4
located in the adjacent myocardium (Fig-
ure 1B). Inactivation of Neuregulin1 or its17, August 18, 2009 ª2009 Elsevier Inc. 151
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PreviewsFigure 1. Proposed Model of Neuregulin-1 Actions in Adult Cardiomyocytes and during
Embryonic Development
(A) Neuregulin-1 induces partial disassembly of the sarcomeric apparatus and stimulates proliferation of
adult cardiomyocytes.
(B) Scheme for the action of neuregulin-1 downstream of notch and the notch-activated RBPjk effector
transcription factor during embryonic heart development.receptors erbB2 and erbB4 results in a
lack of trabeculation, a process that
involves myocyte proliferation, resulting
in abnormally thin myocardium and
enlarged ventricles, which causes death
before midgestation. Similar phenotypes
have been described for mutations in the
ShcA gene. ShcA encodes an adaptor
protein that transmits signals from the
erbB2/erbB4 heterodimer, other tyrosine
kinase receptors, and 5HT-2B, a G pro-152 Developmental Cell 17, August 18, 2009tein-coupled serotonin receptor. During
development 5HT-2B mutants show
reduced erbB2 levels in the myocardium,
suggesting crosstalk between the two
pathways and adding further complexity
to cardiomyocyte regulation (for a review
see Pentassuglia and Sawyer, 2009).
The lack of trabeculation in Neuregulin1
mutants initially suggested that Neuregu-
lin1 might be involved in the control
of proliferation or survival of embryonicª2009 Elsevier Inc.cardiomyocytes. At first glance, such
a function would seem to fit to the induc-
tion of proliferation of cardiomyocytes by
neureglin1 in adults (Bersell et al., 2009)
and could explain the effects of neuregu-
lin1 via transient reconstitution of an
embryonic signaling pathway. However,
more refined experiments disclosed
a role of neuregulin1 in the differentiation
but not proliferation of trabecular cardio-
myocytes during embryonic develop-
ment. The study found that neuregulin1
could rescue cardiomyocyte differentia-
tion defects caused by a Notch deficiency
but could not increase cardiomyocyte
proliferation. BMP-10, on the other hand,
did promote proliferation (Grego-Bessa
et al., 2007).These experiments sug-
gested a model whereby neuregulin1 is
released from the endocardium down-
stream of notch and EphrinB2/EphB4
signaling to activate erbB2/erbB4 hetero-
dimers in the adjacent myocardium
(Figure 1B). ErbB2/erbB4, via ShcA, then
induce differentiation and maturation of
cardiomyocytes while the proliferative
stimulus is supplied by BMP-10. Since
the Bersell et al. (2009) study shows
that neuregulin1 promotes proliferation
of adult cardiomyocytes, it appears that
neuregulin has distinct effects on embry-
onic and adult cardiomyocytes.
It has become popular to view regener-
ative processes in adults as a reiteration of
developmental processes. It is becoming
clear that this view is anoversimplification.
In fact, recent reports emphasize the inad-
equacy of directly applying knowledge
gained from developmental studies to
regenerative processes in the adult (Lep-
per et al., 2009). It seems that the distinct
effects of neuregulin1 on embryonic and
adult hearts present additional support
for this view.
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Activation of Notch by its transmem
bomb and endocytosis of the ubiq
show that the polarity regulator PA
bomb and to changes in cell fate du
Notch signaling is activated by binding of a
transmembrane ligand of the DSL (Delta,
Serrate, LAG-2) family to the extracellular
domain of the receptor. The binding of the
ligand induces a series of proteolytic cleav-
ages of the receptor that ultimately leads to
the generation of an intracellular fragment
of Notch (Nicd) that enters the nucleus,
binds to a DNA binding protein of the CSL
[CBF1, Su(H), LAG-1] family and activates
transcription (Bray, 2006). A series of
recent papers has shown that the activity
of DSL ligands depends on their monoubi-
quitination, which is a prerequisite for
endocytosis mediated by the epsin
adaptor protein. It is not fully understood
why endocytosis of DSL proteins is
required for their activity. One explanation
may be that endocytosis exerts a mechan-
ical force on the extracellular domain of
Notchbound to its ligandwhile it is endocy-
tosed in the adjacent cell. This forcemay in
turn facilitate the shedding of the extracel-
lular domain of Notch, which would
promote subsequentproteolytic cleavages
of the receptor. Alternatively, ubiquitination
could lead to the sequestration of the
ligand toaspecificendocyticcompartment
inwhich the ligandundergoes furthermodi-
fication (Bray, 2006).
The ubiquitination of DSL ligands
depends on the E3 ubiquitin ligases Neu-Lepper, C., Conway, S.J., and Fan, C.M. (2009).
Nature 460, 627–631.
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ralized and Mind bomb, which are evolu-
tionarily conserved and function in a
tissue-specific manner. Loss-of-function
of both ligases results in accumulation of
DSL ligands at the cell surface and
prevents their endocytosis and activation
(Le Borgne et al., 2005). These findings
clearly showed that Neuralized and Mind
bomb are essential for Notch signaling
and raised the question of how these
proteins are regulated. The work by Ossi-
pova et al. (2009) now shows convincingly
that Mind bomb is regulated at the post-
transcriptional level by the kinase PAR-1,
which so far has been studied mostly
with respect to its function in the control
of cell polarity. In coimmunoprecipitation
experiments followed by mass spectrom-
etry analysis, PAR-1 was identified as
a binding partner of Mind bomb. Phos-
phorylation of Mind bomb by PAR-1 at
a conserved serine residue led to its
degradation, which was dependent on
its E3 ligase activity and the proteasome.
Consistent with this finding, overexpres-
sion of PAR-1 in tissue culture cells led
to reduced ubiquitination of Delta-like 1
(Dll1).
The activity and subcellular localization
of PAR-1 is regulated by atypical protein
kinase C (aPKC), a core component of
the PAR-3/PAR-6/aPKC complex, which
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ading to the degradation of Mind
is a central regulator of cell polarity in
many cell types throughout the animal
kingdom (Suzuki and Ohno, 2006). aPKC
directly phosphorylates PAR-1 at a con-
served threonine residue, leading to its
dissociation from the cortex and inhibition
of its kinase activity (Hurov et al., 2004).
By this mechanism, aPKC restricts the
subcellular localization and activity of
PAR-1 to cortical regions where aPKC is
not present. As a consequence, aPKC
and PAR-1 are localized in a mutually ex-
clusive manner in many polarized cell
types, including the C. elegans zygote,
Drosophila neural stem cells, and mam-
malian andDrosophila epithelial cells (Fig-
ure 1A) (Suzuki and Ohno, 2006; Krahn
et al., 2009). The polarized localization of
aPKC and PAR-1 leads to the segregation
of both proteins into separate daughter
cells upon asymmetric cell division. There
is now a solid body of evidence showing
that aPKC and PAR-1 are not only re-
quired for polarization of the cell prior to
asymmetric cell division, but that they
also have profound effects on the cell
fate of the resulting daughter cells. This
has been shown forDrosophila larval neu-
roblasts, where the cell that inherits aPKC
will maintain a progenitor fate instead
of entering the pathway to terminal neu-
ronal differentiation (Lee et al., 2006).
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